Answers are grounded in this paper and cite their sources.
Retrospective study shows candidiasis predicts 30-day mortality in palliative care patients, suggesting a new marker for end-of-life planning.
Background: Predicting short-term mortality in patients receiving palliative care can help tailor interventions, manage expectations, and improve end-of-life planning. This study explores whether candidiasis, particularly in patients on corticosteroids, is associated with increased 30-day mortality. Methods: We conducted a retrospective study of patients admitted to a specialized palliative care unit in 2022. Data collected included demographics, candidiasis diagnosis (oral/esophageal), corticosteroid use, and mortality. Patients with candidemia were excluded. Of 59 deaths in the unit, 35 had complete records and met inclusion criteria. Results: Of the 35 patients analyzed, 71.4% were female; the median age was 61. Ten patients developed candidiasis, all with advanced cancer and functional decline. Among candidiasis cases, 30-day mortality was 60% versus 0% in those without. Median time from candidiasis diagnosis to death was 19 days. Among corticosteroid users, candidiasis was associated with significantly higher short-term mortality. Conclusions: Candidiasis in patients receiving palliative care—particularly those on corticosteroids—may indicate imminent death. These findings suggest its potential as a simple prognostic marker in resource-limited settings, meriting further prospective validation.
No takes yet. Share an insight, caveat, or question.
Mandim et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: